Javascript must be enabled to continue!
A Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain
View through CrossRef
<i>Background</i>: Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life. However, the treatment of neuropathic pain is a clinical challenge. <i>Objective</i>: To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline. <i>Main ideas</i>: Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain. Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations. <i>Conclusion</i>: The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.
Title: A Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain
Description:
<i>Background</i>: Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life.
However, the treatment of neuropathic pain is a clinical challenge.
<i>Objective</i>: To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline.
<i>Main ideas</i>: Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain.
This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain.
Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations.
<i>Conclusion</i>: The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.
Related Results
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain
NLRP3 inflammasome: a key driver of neuroinflammation and a novel therapeutic target for neuropathic pain
Neuropathic pain represents a serious complication arising from a spectrum of disorders that precipitate lesions within the central and peripheral nervous systems. This disabling p...
The Role of Fat Grafting in Alleviating Neuropathic Pain: A Critical Review of the Literature
The Role of Fat Grafting in Alleviating Neuropathic Pain: A Critical Review of the Literature
Background:
Neuropathic pain is one of the more severe types of chronic pain and presents a great challenge as response to medical therapy remains often unpredictable. ...
Pain in patients with neuromyelitis optica spectrum disorders
Pain in patients with neuromyelitis optica spectrum disorders
Neuromyelitis optica spectrum disorders (NMOSD) are a group of chronic autoimmune diseases of the central nervous system with a relapsing course. Unfortunately, the symptoms of exa...
Blocking Cx43 alleviates neuropathic pain mediated by P2X4 receptor in CCI rats
Blocking Cx43 alleviates neuropathic pain mediated by P2X4 receptor in CCI rats
Abstract
Background: The current treatment strategy for pain is still the application of traditional analgesic drugs to relieve pain but with many side effects. Therefore, ...
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
Abstract
Chemotherapy-induced peripheral neuropathy is a dose-limiting debilitating symptom that can affect many patients treated with anticancer treatments. The res...
A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain
A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain
<i>Background: </i>Chronic cancer-related pain can seriously damage physical and mental health of cancer patients. Eliminating cancer pain is basic righ...

